Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income: 2023-2024

Historic Other Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Dec 2024 value amounting to -$2.1 million.

  • Tonix Pharmaceuticals Holding's Other Non Operating Income fell 2527.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year decrease of 441.26%. This contributed to the annual value of -$2.1 million for FY2024, which is 220.73% down from last year.
  • Tonix Pharmaceuticals Holding's Other Non Operating Income amounted to -$2.1 million in FY2024, which was down 220.73% from $1.7 million recorded in FY2023.
  • Tonix Pharmaceuticals Holding's 5-year Other Non Operating Income high stood at $1.7 million for FY2023, and its period low was -$2.1 million during FY2024.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's median Other Non Operating Income value was -$178,500 (recorded in 2023), while the average stood at -$178,500.
  • Data for Tonix Pharmaceuticals Holding's Other Non Operating Income shows a maximum YoY tumbled of 220.73% (in 2024) over the last 5 years.
  • Over the past 2 years, Tonix Pharmaceuticals Holding's Other Non Operating Income (Yearly) stood at $1.7 million in 2023, then tumbled by 220.73% to -$2.1 million in 2024.